Medical Developments International announces agreement with CSIRO

The Medical Developments International Ltd (ASX:MVP) share price will be on watch today after announcing a new agreement with CSIRO…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Tuesday following the release of a positive announcement.

What did Medical Developments International announce?

This morning Medical Developments International announced that it has signed an extension to its 2017 agreement with national science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO).

The agreement is for the development of new manufacturing technologies for pharmaceutical products.

According to the release, the two parties are aiming to develop the next generation of manufacturing technologies to make small molecule pharmaceutical products at a significantly reduced cost and improved quality, compared with traditional processes.

Medical Developments International will invest up to $5 million in the project over five years. This will be funded through a combination of 60% shares or cash and 40% share options. If the company elects to pay 60% of the fees in shares, they will be issued at the 7-day volume weighted average price (VWAP).

The share options will have a term of 10 years and may only be exercised or vested when a developed technology has been proven to be commercially viable. They will be issued at a 10% discount to the 7-day VWAP at the date of invoice.

The company's chief executive officer, John Sharman, said: "We have seen good progress in the development of multiple continuous flow technologies. Our Lidocaine continuous flow process is in the final stages of development after which it could be ready to go to market. There are several other technologies in various stages of completion. This extension will underwrite MVP as a world leader in continuous flow technology."

CSIRO Manufacturing's Science Director, Dr. Paul Savage, also spoke positively on the agreement.

He said: "CSIRO is delighted to extend our partnership with Medical Developments International to develop this new technology. By introducing transformative processing technologies, CSIRO aims to further assist the global competitiveness and growth of the Australian pharmaceutical manufacturing industry."

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »

A couple stares at the tv in shock, one holding the remote up ready to press.
Mergers & Acquisitions

Telstra share price climbs amid $3.4b Foxtel sale

Who is buying the Foxtel business? Let's find out.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Brokers say these ASX 200 growth stocks could rise 50% to 70%

Analysts think these shares could be dirt cheap and destined to generate big returns.

Read more »

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet
Broker Notes

Why these ASX shares could be top SMSF options in 2025

Analysts are bullish on these high-quality shares. Let's find out why.

Read more »

The words short selling in red against a black background
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Monday

A good start to the week is expected for Aussie investors. Here's what to watch.

Read more »

A businessman compares the growth trajectory of property versus shares.
Opinions

What's the outlook for shares vs. property in 2025?

The experts have put out their new year predictions...

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »